Kalpna Singh

Kalpna Singh is a Senior Associate at Innodata Inc. since June 2021, with previous experience as a Project Trainee at the Indian Pharmacopoeia Commission from January to April 2021, focusing on RP-HPLC analytical method development and validation of the anti-retroviral drug remdesivir. Kalpna obtained a Master of Pharmacy in Pharmaceutical Analysis from Delhi Pharmaceutical Sciences and Research University (DPSRU) from 2019 to 2021 and a Bachelor of Pharmacy from R.V. Northland Institute in Dadri, G.B. Nagar, from 2015 to 2019.